Bausch Health Companies reported $1.26 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 1.28 1.16 Oct/29
FY2026Q2 Jun/2026 1.26 1.03 1.05 Jul/29
FY2026Q1 Mar/2026 0.78 0.71 0.61 Apr/29
FY2025Q4 Dec/2025 1.08 1.25 1.14 Feb/18
FY2025Q3 Sep/2025 1.16 1.1 1.14 Oct/29




Eps Change Date
Amgen USD 6.29 1.14 Jun/2026
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Aurora Cannabis CAD -0.13 0.51 Mar/2026
Bausch Health Companies USD 1.26 0.48 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Danaher USD 1.94 0.12 Jun/2026
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Supernus Pharmaceuticals USD -1.01 1.61 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026
Zoetis USD 1.53 0.05 Mar/2026